Which of the following is true about why alcohol, benzodiazepines, and opioids are discouraged in the treatment of obstructive sleep apnea?

A. These agents are all second line agents in the treatment of obstructive sleep apnea: Alcohol, benzodiazepines, and opioids are not considered therapeutic options for obstructive sleep apnea (OSA), so they are not classified as second-line treatments. Their use is contraindicated rather than reserved for later therapy. B. These agents depress the drive to breathe: Alcohol, benzodiazepines, and opioids act as central nervous system depressants, reducing the responsiveness of the respiratory centers to hypercapnia and hypoxia. In patients with OSA, this can worsen upper airway collapse, prolong apneic episodes, and increase the risk of hypoxemia and serious cardiopulmonary complications. C. These agents lead to addiction: While addiction potential is a concern for benzodiazepines and opioids, and alcohol misuse has health risks, the primary reason they are discouraged in OSA is their respiratory depressant effect rather than their addictive properties. D. These agents lead to nighttime awakenings: Although some sedatives may alter sleep architecture, the main issue in OSA is not increased awakenings but the prolongation and severity of apneic episodes caused by reduced respiratory drive.